Innovation Pharma Provides Study Details for Ongoing Phase 2 Clinical Trial of Brilacidin in Hospitalized COVID-19 Patients — Innovation Pharmaceuticals Inc. – #stocks chatter

By
Mehabe
-
0
529

Innovation Pharma Provides Study Details for Ongoing Phase 2 Clinical Trial of Brilacidin in Hospitalized COVID-19 Patients — Innovation Pharmaceuticals Inc.

http://www.ipharminc.com/press-release/2021/2/26/innovation-pharma-provides-study-details-for-ongoing-phase-2-clinical-trial-of-brilacidin-in-hospitalized-covid-19-patients

RELATED ARTICLESMORE FROM AUTHOR

This site uses Akismet to reduce spam. Learn how your comment data is processed.